
Amneal Pharmaceuticals, Inc. (AMRX) earnings
- Healthcare
- NASDAQ
- Market cap$7.4B
Next report
2027-02-26
In 97 daysQ4 FY2026Time not announced· Expected date
- EPS consensus
- 0.24
- 0.23 – 0.254 analysts
- Revenue consensus
- $838M
- Beat streak
- 3
Latest result
18 days ago+9.5%EPS Beat
Estimate recorded after the release
2026-11-03Q3 FY2026BMO
- EPS
- Reported / estimate0.26 / 0.24
- Revenue
- $863M / $818M+5.5%
Stock reaction
-1.13%
-1.42 pts vs SPY
Session 2026-11-03
Recent quarters
Latest 3 quartersRevenue and stock reaction
Beat in 3 of 3 quarters with a measured stock reaction · beat then fell 3
| Quarter | EPSReported / estimate | RevenueReported / estimate | Reaction |
|---|---|---|---|
Q3 FY2026 2026-11-03 | 0.26 / 0.24 +9.5%¶ | $863M / $818M +5.5%¶ | -1.13% -1.42 pts vs SPY |
Q2 FY2026 2026-07-30 | 0.30 / 0.22 +34.8%¶ | $796M / $768M +3.6%¶ | -3.14% -4.82 pts vs SPY |
Q1 FY2026 2026-05-07 | 0.27 / 0.17 +58.8%¶ | $723M / $720M +0.4%¶ | -3.79% -4.62 pts vs SPY Session 2026-05-08 |
Reported / estimate
- Q3 FY2026 · 2026-11-03-1.13%EPS0.26 / 0.24+9.5%¶Revenue$863M / $818M+5.5%¶
- Q2 FY2026 · 2026-07-30-3.14%EPS0.30 / 0.22+34.8%¶Revenue$796M / $768M+3.6%¶
- Q1 FY2026 · 2026-05-07-3.79%EPS0.27 / 0.17+58.8%¶Revenue$723M / $720M+0.4%¶
- ¶Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.
Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.